#United States #New York #The Gross Law Firm #Kyverna Therapeutics #KYTX

Kyverna Therapeutics Class Action Update

The Gross Law Firm has issued a reminder to investors of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) regarding an impending class action lawsuit. Shareholders who acquired shares during the specified period are encouraged to engage with the firm concerning possible appointments as lead plaintiffs. Participation as a lead plaintiff is not a prerequisite for potential recovery in the class action.

Important Information for Shareholders

The class action lawsuit is on behalf of those who purchased or acquired Kyverna common stock that was associated with the company's offering documents during its initial public offering (IPO) in February 2024. The complaint claims that during this timeframe, the defendants may have issued materially misleading statements or failed to disclose crucial information, impacting shareholders’ investment decisions.

Allegations Against Kyverna Therapeutics

According to the complaint, essential allegations include:

• - The defendants allegedly misrepresented the strategy to execute the IPO effectively.
• - Claims about the IPO’s terms, including stock pricing and details reflected in the Offering Documents, were allegedly misleading or incorrect.
• - The defendants may have failed to disclose significant issues and concerns that would be relevant to investing in the stock.

These issues have raised significant concerns among investors who might have relied on potentially false information from Kyverna. The communication lines between Kyverna’s management and its underwriters are scrutinized, suggesting possible lapses in transparency that could have affected the integrity of the offering.

Key Deadline Approaching

Shareholders are advised to act promptly, as the deadline to register for this class action is fast approaching on February 7, 2025. Those who register will be enrolled in a portfolio monitoring service to track the case’s progress. Importantly, there are no costs associated with signing up for this case, and participation is without obligation.

Next Steps for Interested Investors

For anyone interested in becoming involved or seeking more information, it’s critical to register through the provided link by the deadline stated. This will ensure that you remain informed of updates regarding the lawsuit and gain access to resources designed to assist shareholders throughout the legal proceedings.

About The Gross Law Firm

The Gross Law Firm is recognized nationwide for its commitment to protecting investors’ rights. The firm strives to hold accountable companies that engage in misleading practices that lead to financial losses for investors. They emphasize the importance of corporate accountability and engage in legal battles for justice on behalf of aggrieved shareholders.

Contact Information

For more detailed inquiries, potential and existing shareholders can reach out to The Gross Law Firm:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Investors are encouraged to stay vigilant and protect their interests during this crucial period as the firm continues to advocate for fair practices in the securities markets.